Heart attack | Page 17 of 45

High Blood Pressure :: One pill may be better than two for treating patients with high blood pressure

Adults with high blood pressure and additional risk factors for heart disease may benefit more from taking one tablet rather than two, if their current treatment combines the lipid-lowering medication atorvastatin with the blood pressure-lowering medication amlodipine, researchers reported at the American Heart Association’s 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.

Heart Attack :: High-dose anticlotting drug cuts heart attack

Pretreatment with double-dose anticlotting medication just before percutaneous coronary intervention cuts the combined risk of heart attack and cardiac death by half, according to a study reported at the 30th annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions, May 9-12, 2007, in Orlando, Fla.

Heart Attack :: Heart attack tests recalled

A recall has been issued for the VITROS Immunodiagnostic Products Troponin I Reagent Pack, a medical test used to diagnose heart attack or injury to the heart muscle. The recall refers specifically to lot numbers 3151 and 3170.

Stent :: Panel offers expert analysis on causes, prevention of stent thrombosis

Over the last year, it’s been rare to utter the word “stent” without at least thinking “thrombosis,” an uncommon but serious complication that’s been on the minds of interventional cardiologists and patients alike.

Heart :: Novel catheter technique successfully patches holes in the heart

A novel catheter technique for patching holes in the heart may make it possible for many patients to avoid surgery altogether and others to regain enough strength to safely undergo surgical repair at a later date, according to a study reported at the 30th annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions, May 9-12, 2007, in Orlando, Fla.

Stent :: ENDEAVOR III Trial reports key findings on new-generation stent

New data reported at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions, May 9-12, 2007, in Orlando, Fla., will offer clues to the fate of a new-generation drug-eluting stent that is vying for a place in the treatment of coronary artery disease.

Heart Attack :: Most young women don’t recognize heart attack warning signs

Most women 55 years and younger who have heart attacks don’t recognize warning signs, researchers reported at the American Heart Association’s 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.

Angioplasty :: Angioplasty reduces cardiac risk in silent heart attack

When compared with intensive drug therapy, percutaneous coronary intervention (PCI, angioplasty) was more beneficial in reducing the long-term risk of major cardiac events among heart attack survivors with “silent ischemia”, according to a study in the May 9 issue of JAMA.

Heart :: Ortho-Clinical Diagnostics recalls Cardiac Marker

Ortho-Clinical Diagnostics, Inc. has initiated a voluntary, nationwide recall of two lots of a diagnostic test used by physicians to aid in the diagnosis of injury to heart muscle and/or heart attack because of shifts in test results that could contribute to a missed diagnosis of myocardial infarction.

Stent :: Off-label and untested use of drug-coated stents appears widespread

The off-label and untested use of drug-coated stents in the treatment of coronary artery blockage is common in US practice, and ischemic complication rates are higher among patients receiving drug-coated stents for off-label indications, according to two studies in the May 9 issue of JAMA.